A PHASE 1, OPEN LABEL STUDY EVALUATING THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ARV-471 (PF-07850327) AS A SINGLE AGENT IN CHINESE PARTICIPANTS WITH ER+/HER2- ADVANCED BREAST CANCER
| Title | A PHASE 1, OPEN LABEL STUDY EVALUATING THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ARV-471 (PF-07850327) AS A SINGLE AGENT IN CHINESE PARTICIPANTS WITH ER+/HER2- ADVANCED BREAST CANCER |
|---|---|
| Description | Pfizer C4891018 Targeted genome sequencing data after screening for 9 participants |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA029840 |
| Release Date | 2024-10-15 |
| Submitter | Rong Cao (rong.cao@pfizer.com) |
| Organization | Pfizer (China) Research and Development Co. Ltd. |
| Submission Date | 2024-09-04 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX007275-01 | C4891018 Targeted Genome Sequencing Data After Screening Aug2024 | 1 | Other Type of Genomic Data | 229.7 KB | zip | 0 | Unavailable |